You are here

cadazolid

J&J dumps a failed PhIII antibiotic program picked up in Actelion buyout

Endpoints

Tue, 04/17/18 - 11:08 am

Johnson & Johnson’s $30B buyout suffers setback as Actelion antibiotic fails in one phase 3, succeeds in another

Fierce Biotech

Thu, 06/8/17 - 09:38 am

clinical trials

Actelion Drug to Move into Phase III

Yahoo/Zacks

Wed, 12/26/12 - 09:24 pm

Clostridium Difficile